Share Your Story
Share Your Story
Funding November 19, 2026

VitusCare Raises $3 Million in Series B to Take Its Dialysis Network Past 100 Centres

VitusCare has raised nearly Rs 30 crore in a Series B round to grow its dialysis network past 100 centres and build AI tools and a technician academy.

Gurugram-based dialysis care provider VitusCare has raised nearly Rs 30 crore, about $3 million, in a Series B funding round. The company will use the money to open more centres, build new technology and train dialysis technicians.

The round drew in Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis and NAFA Capital Advisors. Existing investors 1Crowd and 3i Partners joined in, along with several angel investors. VitusCare announced the raise on November 19.

What the money will fund

VitusCare will spend the fresh capital on network expansion, technology development and workforce training. The technology work includes AI-native business modules for running its centres, while the training push centres on a new Technician Academy.

Every new centre needs trained technicians on site, so the academy is part of the expansion plan rather than an add-on. It is aimed at strengthening the pipeline of skilled dialysis professionals as the network scales.

From 22 centres to more than 60

The raise follows a sharp run of growth. VitusCare says its revenue has risen nearly three times since its last funding round in late 2024, while its network has grown from 22 centres to more than 60 across nine states and over 50 cities.

The company has treated more than 35,000 patients and delivered over 8 lakh dialysis sessions. Revenue stood at around Rs 44 crore in FY26, and VitusCare is targeting nearly Rs 65 crore in FY27.

The next milestone is scale. VitusCare aims to cross 100 centres by the end of FY27 and is exploring opportunities in select Asian markets.

A shop-in-shop model built for smaller cities

VitusCare runs its centres inside existing hospitals, a capital-light shop-in-shop model that lets it open where a standalone unit would struggle. Its focus is Tier 2, 3 and 4 cities, where dialysis access is thinnest.

Large hub centres are paired with smaller satellite units within about 50 km, cutting the distance patients must travel for treatment that typically happens three times a week. Cashless treatment is available to patients covered by government and private insurance schemes.

VitusCare was founded in 2017 by Prabhat Shrivastava, Dr Saurabh Pokhariyal and Pankaj Tandon. It raised Rs 10 crore in its first institutional round in 2020, followed by Rs 22 crore in mid-2024 in a round led by Tomorrow Capital.

The gap VitusCare is chasing

India adds about 2.2 lakh new end-stage renal disease patients every year, creating demand for 3.4 crore dialysis sessions a year, according to government data. Dialysis alone costs a patient around Rs 2.4 lakh a year, before tests, medicines and travel.

The market is growing with the need. India’s dialysis market is expected to rise from $2.1 billion in 2022 to $4.4 billion by 2030, a compound annual growth rate of 9.5 percent. Organised chains are moving fast to serve it, and larger rival NephroPlus has raised $102 million from Quadria Capital.

“This fundraise marks an important milestone in VitusCare’s journey. We are focused on building a sustainable dialysis care model that combines clinical excellence with operational efficiency. The confidence our investors have shown in us reinforces our approach to disciplined growth, improving centre-level performance and strengthening our operational foundation. As we expand our network, we remain focused on maintaining consistent care standards while making quality dialysis services more accessible across underserved markets.”

Prabhat Shrivastava, Founder and CEO, VitusCare

The round is modest next to the sums raised by the biggest dialysis chains. But VitusCare is not chasing the metros. It is building where dialysis is hardest to reach, and this raise buys the centres, the technology and the trained people to keep that model growing.